We are live on
!
Find out more
BOCH
Blue Owl Capital Holdings Portfolio holdings
AUM
$372M
1-Year Est. Return
78.25%
This Fund
S&P 500
This Quarter
Est. Return
+12.37%
1 Year Est. Return
+78.25%
3 Year Est. Return
+112.77%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$310M
AUM Growth
-$220K
(-0.07%)
Cap. Flow
-$11.6M
Cap. Flow
% of AUM
-3.74%
Top 10 Holdings %
Top 10 Hldgs %
66.11%
Holding
86
New
13
Increased
6
Reduced
14
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TEM
Tempus AI
TEM
|
+$4.6M |
| 2 |
Ultragenyx Pharmaceutical
RARE
|
+$3.68M |
| 3 |
FLD
Fold Holdings
FLD
|
+$3.68M |
| 4 |
Starwood Property Trust
STWD
|
+$2.55M |
| 5 |
Biomea Fusion
BMEA
|
+$2.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares UltraPro QQQ
TQQQ
|
+$10M |
| 2 |
CMPS
Compass Pathways
CMPS
|
+$3.41M |
| 3 |
ETWO
E2open Parent Holdings
ETWO
|
+$3.3M |
| 4 |
Tango Therapeutics
TNGX
|
+$3.23M |
| 5 |
Conduent
CNDT
|
+$2.91M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 51.14% |
| 2 | Financials | 31.24% |
| 3 | Technology | 10.9% |
| 4 | Consumer Discretionary | 5.02% |
| 5 | Real Estate | 0.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Keros Therapeutics
KROS
$221M
| – | – |
-266,033
| Closed | -$2.71M |
|
77
NextNav
NN
$2.23B
| – | – |
-198,760
| Closed | -$2.42M |
|
78
Roivant Sciences
ROIV
$26.2B
| – | – |
-39,003
| Closed | -$394K |
|
|
79
ProShares UltraPro QQQ
TQQQ
$37.4B
| – | – |
-350,000
| Closed | -$10M |
|
|
VSTEW
80
DELISTED
Vast Renewables Limited Warrants
VSTEW
| – | – |
-200,000
| Closed | -$6K |
|
|
ZAPPW
81
DELISTED
Zapp Electric Vehicles Group Limited Warrant
ZAPPW
| – | – |
-1,930,986
| Closed | -$19.3K |
|
|
ZCARW
82
DELISTED
Zoomcar Holdings, Inc. Warrants
ZCARW
| – | – |
-250,000
| Closed | -$2.5K |
|
83
Critical Metals Corp
CRML
$1.06B
| – | – |
-67,718
| Closed | -$94.1K |
|
|
PITAW
84
DELISTED
Heramba Electric plc Warrants
PITAW
| – | – |
-989,998
| Closed | -$9.9K |
|
|
GATE
85
DELISTED
Marblegate Acquisition Corp. Class A Common Stock
GATE
| – | – |
-91,429
| Closed | -$1.37M |
|
|
GATEW
86
DELISTED
Marblegate Acquisition Corp. Warrant
GATEW
| – | – |
-597,333
| Closed | -$95.6K |
|
Similar funds
PC
GIP
DPCM
SAAM
KP
TCM
PAA
JC
Blue Owl Capital Holdings's Q2 2025 Portfolio in Review
As of Q2 2025, Blue Owl Capital Holdings held 86 positions worth $310M, down 0.07% from $310M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Blue Owl Capital Holdings withdrew a net $11.6M in Q2 2025, closing 14 positions and reducing 14 holdings. Its most notable exit was ProShares UltraPro QQQ, an estimated $10M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 44% a quarter earlier, followed by Financials and Technology.
Against the trend, Blue Owl Capital Holdings opened a new position in Tempus AI worth $5.09M.
- Blue Owl Capital Holdings's largest Q2 2025 buy was Tempus AI: 80,167 shares worth $5.09M.
- Blue Owl Capital Holdings added most to Ultragenyx Pharmaceutical in Q2 2025, an estimated $3.68M increase.
- Blue Owl Capital Holdings's biggest Q2 2025 reduction was Compass Pathways, cutting an estimated $3.41M.
- Blue Owl Capital Holdings fully exited ProShares UltraPro QQQ in Q2 2025, selling an estimated $10M.
- Blue Owl Capital Holdings's ten largest holdings make up 66% of its $310M portfolio in Q2 2025.
- Blue Owl Capital Holdings opened 13 new positions and closed 14 in Q2 2025.
- Blue Owl Capital Holdings's portfolio value fell 0.07% quarter-over-quarter to $310M.
Based on Blue Owl Capital Holdings's 13F filing for Q2 2025, filed 11 Aug 2025.